13
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Successful Treatment of Chylous Ascites Secondary to Sarcoidosis with Methotrexate

, MD, MS, , MD & , MD
Pages 144-146 | Published online: 24 Jun 2015

References

  • Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med. 1982;96(3):358–364.
  • C´rdenas A, Chopra S. Chylous ascites. Am J Gastroenterol. 2002; 97(8): 1896–1900.
  • Cappell MS, Friedman D, Mikhail N. Chyloperitoneum associated with chronic severe sarcoidosis. Am J Gastroenterol. 1993;88(1):99–101.
  • Provenza JM, Bacon BR. Chylous ascites due to sarcoidosis. Am J Gastroenterol. 1991; 86(1):92–95.
  • Sontag S, Chejfec G, Stanley M, Nemchausky B. Postsurgical chylous ascites in sarcoidosis with portal hypertension. J Clin Gastroenterol. 1985; 7(4):327–330.
  • Hurley MK, Emiliani VJ, Comer GM, Patel A, Navarro C, Maiki CO. Dilated cardiomyopathy associated with chylous ascites. AmJ Gastroenterol. 1989; 84(12): 1567–1569.
  • Güneri S, Nazli C, Kinay O, Kirimli O, Mermut C, Hazan E. Chylous ascites due to constrictive pericarditis. Int J Card Imaging. 2000; 16(1):49–54.
  • Cheng WS, Gough IR, Ward M, Croese J, Powell LW. Chylous ascites in cirrhosis: a case report and review of the literature. J Gastroenterol Hepatol. 1989; 4(1):95–99.
  • Campisi C, Bellini C, Eretta C, et al. Diagnosis and management of primary chylous ascites. J Vase Surg. 2006; 43(6): 1244–1248.
  • Laterre PF, Dugemier T, Rcynaert MS. Chylous ascites: diagnosis, causes and treatment. Acta Gastroenterol Belg. 2000; 63(3):260–263.
  • Aalami OO, Allen DB, Organ CH Jr. Chylous ascites: a collective review. Surgery. 2000; 128(5):761–778.
  • Shapiro AM, Bain VG, Sigalet DL, Kneteman NM. Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition. Transplantation. 1996; 61 (9): 1410–1411.
  • Cronstein BN. The mechanism of action of methotrexate. Rheum Dis Clin North Am. 1997; 23(4):739–755.
  • Vucinic VM. What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med. 2002; 8(5):470–476.
  • Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160(2):736–755.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.